Pfizer, Cisco, Arch Capital And More: CNBC's 'Final Trades'
On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said he is staying long on Pfizer Inc. (NYSE:PFE).
On July 11, Pfizer announced it will advance the development of Danuglipron. The company selected the once-daily weight loss drug for continued advancement based on an ongoing pharmacokinetic study.
Bryn Talkington of Requisite Capital Management named Pacer US Cash Cows 100 ETF (CBOE: COWZ) as her final trade.
Don't forget to check out our premarket coverage here
Joe Terranova of Virtus Investment Partners picked Arch Capital Group Ltd. (NASDAQ:ACGL), which is a financial stock.
Arch Capital Group will release its its second quarter results after the closing bell on Tuesday, July 30. Analysts expect the company to report quarterly earnings at $2.21 per share, up from $1.92 per share in the year-ago period. The company is projected to post quarterly revenue of $3.99 billion, compared to $3.34 billion a year earlier.
Jim Lebenthal of Cerity Partners said higher highs and higher lows shows the downtrend is over in Cisco Systems, Inc. (NASDAQ:CSCO) stock.
Cisco is reportedly planning to establish a cybersecurity center in Taiwan and collaborate with the local government to expand the cybersecurity workforce. The company unveiled the initiative as part of its ongoing efforts to enhance digital security infrastructure in regions facing high cyber threat levels, reported Reuters.
Price Action:
- Pfizer shares gained 1.8% to close at $30.03 on Wednesday.
- Pacer US Cash Cows 100 ETF slipped 0.1% during Wednesday's session.
- Arch Capital shares gained 0.8% to close at $97.87 on Wednesday.
- Cisco shares gained 2.3% to close at $48.52 during Wednesday's session.
Check This Out:
Image: Shutterstock